Antares Therapeutics
Organisation
Trials
A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors
Phase 1/2, Recruiting, 343 people, 17 Aug 2026
Sources: clinicaltrials.gov
Named in competing interests
Shares or equity, 2 Oct 2026
Shares or equity, 20 Feb 2026
Sources: pubmed.ncbi.nlm.nih.gov